Samsung Biologics (207940:KS) PT Lowered to KRW1,140,000 at Credit Suisse

February 3, 2023 12:06 PM EST
Get Alerts 207940:KS Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 15 | Down: 9 | New: 13
Join SI Premium – FREE
Credit Suisse analyst Ray Kim lowered the price target on Samsung Biologics (207940:KS) to KRW1,140,000.00 (from KRW1,180,000.00) while maintaining a Outperform rating.

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Intl Ratings